Vertex Pharmaceuticals Stock Likely To Trend Higher After The Recent 11% Drop

The stock price of Vertex Pharmaceuticals (VRTX) has seen a decline of 7% over the last five trading days, while it’s down 11% over the last ten trading days. This drop can largely be attributed to the company’s Q4 results, with EPS missing the consensus estimates.

The stock price of Vertex Pharmaceuticals (VRTX) has seen a decline of 7% over the last five trading days, while it’s down 11% over the last ten trading days. This drop can largely be attributed to the company’s Q4 results, with EPS missing the consensus estimates.